Literature DB >> 20069350

The PDZ domain binding motif (PBM) of human T-cell leukemia virus type 1 Tax can be substituted by heterologous PBMs from viral oncoproteins during T-cell transformation.

Tomoya Aoyagi1, Masahiko Takahashi, Masaya Higuchi, Masayasu Oie, Yuetsu Tanaka, Tohru Kiyono, Yutaka Aoyagi, Masahiro Fujii.   

Abstract

Several tumor viruses, such as human T-cell leukemia virus (HTLV), human papilloma virus (HPV), human adenovirus, have high-oncogenic and low-oncogenic subtypes, and such subtype-specific oncogenesis is associated with the PDZ-domain binding motif (PBM) in their transforming proteins. HTLV-1, the causative agent of adult T-cell leukemia, encodes Tax1 with PBM as a transforming protein. The Tax1 PBM was substituted with those from other oncoviruses, and the transforming activity was examined. Tax1 mutants with PBM from either HPV-16 E6 or adenovirus type 9 E4ORF1 are fully active in the transformation of a mouse T-cell line from interleukin-2-dependent growth into independent growth. Interestingly, one such Tax1 PBM mutant had an extra amino acid insertion derived from E6 between PBM and the rest of Tax1, thus suggesting that the amino acid sequences of the peptides between PBM and the rest of Tax1 and the numbers only slightly affect the function of PBM in the transformation. Tax1 and Tax1 PBM mutants interacted with tumor suppressors Dlg1 and Scribble with PDZ-domains. Unlike E6, Tax1 PBM mutants as well as Tax1 did not or minimally induced the degradations of Dlg1 and Scribble, but instead induced their subcellular translocation from the detergent-soluble fraction into the insoluble fraction, thus suggesting that the inactivation mechanism of these tumor suppressor proteins is distinct. The present results suggest that PBMs of high-risk oncoviruses have a common function(s) required for these three tumor viruses to transform cells, which is likely associated with the subtype-specific oncogenesis of these tumor viruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20069350     DOI: 10.1007/s11262-009-0447-x

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  27 in total

Review 1.  Deregulation of cell-signaling pathways in HTLV-1 infection.

Authors:  William W Hall; Masahiro Fujii
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  The PDZ domain-binding motif of the human T cell leukemia virus type 1 tax protein induces mislocalization of the tumor suppressor hScrib in T cells.

Authors:  Charlotte Arpin-André; Jean-Michel Mesnard
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

3.  The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes.

Authors:  T M Ross; S M Pettiford; P L Green
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.

Authors:  S L Cross; M B Feinberg; J B Wolf; N J Holbrook; F Wong-Staal; W J Leonard
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

5.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

6.  Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.

Authors:  Y Tanaka; A Yoshida; H Tozawa; H Shida; H Nyunoya; K Shimotohno
Journal:  Int J Cancer       Date:  1991-06-19       Impact factor: 7.396

Review 7.  HTLV-1 Tax and adult T-cell leukemia.

Authors:  Chou-Zen Giam; Kuan-Teh Jeang
Journal:  Front Biosci       Date:  2007-01-01

Review 8.  Cell polarity proteins: common targets for tumorigenic human viruses.

Authors:  R T Javier
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

9.  Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein.

Authors:  Kojiro Ishioka; Masaya Higuchi; Masahiko Takahashi; Sakiko Yoshida; Masayasu Oie; Yuetsu Tanaka; Sugata Takahashi; Li Xie; Patrick L Green; Masahiro Fujii
Journal:  Retrovirology       Date:  2006-10-17       Impact factor: 4.602

10.  The discovery of the first human retrovirus: HTLV-1 and HTLV-2.

Authors:  Robert C Gallo
Journal:  Retrovirology       Date:  2005-03-02       Impact factor: 4.602

View more
  6 in total

1.  The pleiotropic protein kinase CK2 phosphorylates HTLV-1 Tax protein in vitro, targeting its PDZ-binding motif.

Authors:  Carlo Bidoia; Marco Mazzorana; Mario A Pagano; Giorgio Arrigoni; Flavio Meggio; Lorenzo A Pinna; Umberto Bertazzoni
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

Review 2.  Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses.

Authors:  Ronald T Javier; Andrew P Rice
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

Review 3.  Polarity and lymphocyte fate determination.

Authors:  John T Chang
Journal:  Curr Opin Cell Biol       Date:  2012-06-02       Impact factor: 8.382

4.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

5.  HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.

Authors:  Jacob Al-Saleem; Wessel P Dirksen; Michael P Martinez; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Lee Ratner; Patrick L Green
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

Review 6.  Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?

Authors:  Claire D James; Sally Roberts
Journal:  Pathogens       Date:  2016-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.